Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2024-04-03 00:00:00 ET · period of report 2024-04-01 · accession 0001968202-24-000090 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-04-03 | 2024-04-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $962.53 | -100 | 18.3K | -0.5% | -$96.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | S | D | 2 | $957.78 | 18,280 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-01 | S | D | 2 | $958.86 | 18,278 | D | — | — | |
| 3 | Common | Common Stock | 2024-04-01 | S | D | 13 | $965.35 | 18,182 | D | — | — | (F8) Represents volume-weighted average price of sales of 13 shares of Company stock on April 1, 2024 at prices ranging from $965.00 to $965.82. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. |
| 4 | Common | Common Stock | 2024-04-01 | S | D | 16 | $964.45 | 18,195 | D | — | — | (F7) Represents volume-weighted average price of sales of 16 shares of Company stock on April 1, 2024 at prices ranging from $964.02 to $964.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. |
| 5 | Common | Common Stock | 2024-04-01 | S | D | 20 | $963.60 | 18,211 | D | — | — | (F6) Represents volume-weighted average price of sales of 20 shares of Company stock on April 1, 2024 at prices ranging from $963.02 to $963.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. |
| 6 | Common | Common Stock | 2024-04-01 | S | D | 9 | $962.42 | 18,231 | D | — | — | (F5) Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2024 at prices ranging from $962.06 to $962.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. |
| 7 | Common | Common Stock | 2024-04-01 | S | D | 14 | $961.59 | 18,240 | D | — | — | (F4) Represents volume-weighted average price of sales of 14 shares of Company stock on April 1, 2024 at prices ranging from $961.10 to $961.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. |
| 8 | Common | Common Stock | 2024-04-01 | S | D | 9 | $959.47 | 18,269 | D | — | — | (F2) Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2024 at prices ranging from $959.13 to $959.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. |
| 9 | Common | Common Stock | 2024-04-01 | S | D | 15 | $960.53 | 18,254 | D | — | — | (F3) Represents volume-weighted average price of sales of 15 shares of Company stock on April 1, 2024 at prices ranging from $960.06 to $960.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2024 at each separate price. |